Level D· Scientific groundwork from lab and animal studiesLaboratory StudyPubMedOpen access

Global trends on exosomes in spinal cord injury: A bibliometric analysis and mini-review.

Shang J., Xu H., Xie L., Lv H., Wang F., Jin C.

Laboratory Study on Spinal Cord Injury, published in Biomater Transl (2025) — summary generated from the PubMed abstract.

Open my reading list
Level D· Scientific groundwork from lab and animal studiesEvidence level of this study

Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.

  • Level A · Stronger Clinical Evidence
  • Level B · Emerging clinical evidence with positive signals
  • Level C · Early human research exploring benefits
  • Level D · Scientific groundwork from lab and animal studies
  • Emerging · Emerging topic under active research
Read the A–D evidence level guide

This page is generated from the PubMed record. The Thai description is an automated summary of bibliographic fields and the abstract, not a full translation, and is not medical advice.

Study type
Laboratory Study
Journal
Biomater Transl (2025)
Country
China
Reported sample size
—
Source database
PubMed
PMID
40641991
PMCID
PMC12237805
DOI
10.12336/bmt.24.00004
Citations
1

Abstract (original English)

Spinal cord injury (SCI) is recognised as a debilitating condition that often leads to considerable disability and functional limitations. Exosomes, which can be derived from various cell types including bone marrow mesenchymal stem cells, adipose-derived stem cells, dental pulp stem cells, and macrophages, play a pivotal role in the post-SCI landscape. Collectively, it has been observed that these exosomes can modulate the immune response following SCI, regulate the inflammatory environment, inhibit secondary tissue damage, and support neuronal survival and axonal regrowth. However, it is noted that exosomes from different sources exhibit distinct characteristics. Therefore, it is deemed essential to gain a comprehensive understanding of the current knowledge and research directions regarding exosomes in SCI to foster the development of effective therapeutic interventions. In this bibliometric analysis, we conducted to search retrieve pertinent articles from the Web of Science Core Collection and identify pivotal publications, authors, institutions, countries, and keywords that have contributed significantly to the field. This bibliometric analysis offers a thorough examination of the present knowledge landscape and prevailing research trends pertaining to exosomes in the context of SCI. It acts as a valuable asset, catering not only to researchers but also to clinicians and p

What this study does not prove

  • • This study does not prove SVF is an approved treatment or a replacement for standard care.
  • • This is preclinical work; animal or laboratory results cannot be applied to humans.

Evidence level

Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.

How we grade evidence

Browse all related research

Filter the research library by this study's title keywords, author, or publication year.

Related research